What is the current market valuation of the France predictive genetic testing consumer wellness genomics market?

As of 2024, the market valuation stands at 174.38 USD Million. Read More

What is the projected market size for the France predictive genetic testing consumer wellness genomics market by 2035?

The market is expected to reach a valuation of 393.17 USD Million by 2035. Read More

Which segments are included in the France predictive genetic testing consumer wellness genomics market?

Key segments include Health Risk Assessment, Carrier Testing, Ancestry Testing, Pharmacogenomics, and Nutrigenomics. Read More

What are the projected valuations for the Health Risk Assessment segment by 2035?

The Health Risk Assessment segment is projected to grow from 30.0 USD Million to 70.0 USD Million. Read More

How does the Direct-to-Consumer segment perform in the market?

The Direct-to-Consumer segment is expected to increase from 70.0 USD Million to 150.0 USD Million by 2035. Read More

What technologies are driving the France predictive genetic testing market?

Technologies such as Next Generation Sequencing, Microarray Technology, Sanger Sequencing, and PCR Technology are pivotal. Read More

What is the expected growth for the Nutrigenomics segment by 2035?

Nutrigenomics is projected to expand from 59.38 USD Million to 123.17 USD Million. Read More

Which companies are considered key players in the France predictive genetic testing market?

Key players include 23andMe, MyHeritage, Ancestry, Genetic Health, and DNAfit. Read More

What regulatory factors influence the France predictive genetic testing market?

Regulatory factors include Data Privacy Regulations, Testing Standards, Ethical Guidelines, and Insurance Coverage. Read More

France Predictive Genetic Testing Consumer Wellness Genomics Market

Q: What is the expected CAGR for the France predictive genetic testing consumer wellness genomics market during the forecast period 2025 - 2035?

The market is anticipated to grow at a CAGR of 7.67% from 2025 to 2035. Read More

ID: MRFR/LS/50121-HCR

200 Pages

Satyendra Maurya

Last Updated: March 28, 2026

France Predictive Genetic Testing and Consumer Wellness Genomics Market Research Report By Test Type (Predictive Testing, Consumer Genomics, Wellness Genomics), By Application (Breast & Ovarian Cancer, Cardiovascular Screening, Diabetic Screening & Monitoring, Colon Cancer, Parkinsonism/Alzheimer’s Disease, Urologic Screening/Prostate Cancer Screening, Orthopedic & Musculoskeletal, Others), and By Setting Type (Proteomic Testing, Metabolic Testing, Genomic Testing) - Growth & Industry Forecast 2025 To 2035

France Predictive Genetic Testing Consumer Wellness Genomics Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Health Risk Assessment
  2. 4.1.2 Carrier Testing
  3. 4.1.3 Ancestry Testing
  4. 4.1.4 Pharmacogenomics
  5. 4.1.5 Nutrigenomics
2. 4.2 Healthcare, BY End Use (USD Million)
  1. 4.2.1 Healthcare Providers
  2. 4.2.2 Direct-to-Consumer
  3. 4.2.3 Research Institutions
  4. 4.2.4 Pharmaceutical Companies
3. 4.3 Healthcare, BY Technology (USD Million)
  1. 4.3.1 Next Generation Sequencing
  2. 4.3.2 Microarray Technology
  3. 4.3.3 Sanger Sequencing
  4. 4.3.4 PCR Technology
4. 4.4 Healthcare, BY Consumer Demographics (USD Million)
  1. 4.4.1 Age Group
  2. 4.4.2 Gender
  3. 4.4.3 Income Level
  4. 4.4.4 Education Level
5. 4.5 Healthcare, BY Regulatory Environment (USD Million)
  1. 4.5.1 Data Privacy Regulations
  2. 4.5.2 Testing Standards
  3. 4.5.3 Ethical Guidelines
  4. 4.5.4 Insurance Coverage
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 23andMe (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 MyHeritage (IL)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Ancestry (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Genetic Health (FR)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 DNAfit (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Invitae (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Fulgent Genetics (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 GenoPalate (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 GenePlanet (SI)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 FRANCE MARKET ANALYSIS BY APPLICATION
3. 6.3 FRANCE MARKET ANALYSIS BY END USE
4. 6.4 FRANCE MARKET ANALYSIS BY TECHNOLOGY
5. 6.5 FRANCE MARKET ANALYSIS BY CONSUMER DEMOGRAPHICS
6. 6.6 FRANCE MARKET ANALYSIS BY REGULATORY ENVIRONMENT
7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF HEALTHCARE
10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
17. 6.17 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
19. 6.19 HEALTHCARE, BY CONSUMER DEMOGRAPHICS, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY CONSUMER DEMOGRAPHICS, 2024 TO 2035 (USD Million)
21. 6.21 HEALTHCARE, BY REGULATORY ENVIRONMENT, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY REGULATORY ENVIRONMENT, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  2. 7.2.2 BY END USE, 2026-2035 (USD Million)
  3. 7.2.3 BY TECHNOLOGY, 2026-2035 (USD Million)
  4. 7.2.4 BY CONSUMER DEMOGRAPHICS, 2026-2035 (USD Million)
  5. 7.2.5 BY REGULATORY ENVIRONMENT, 2026-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

France Healthcare Market Segmentation

Healthcare By Application (USD Million, 2026-2035)

Health Risk Assessment
Carrier Testing
Ancestry Testing
Pharmacogenomics
Nutrigenomics

Healthcare By End Use (USD Million, 2026-2035)

Healthcare Providers
Direct-to-Consumer
Research Institutions
Pharmaceutical Companies

Healthcare By Technology (USD Million, 2026-2035)

Next Generation Sequencing
Microarray Technology
Sanger Sequencing
PCR Technology

Healthcare By Consumer Demographics (USD Million, 2026-2035)

Age Group
Gender
Income Level
Education Level

Healthcare By Regulatory Environment (USD Million, 2026-2035)

Data Privacy Regulations
Testing Standards
Ethical Guidelines
Insurance Coverage

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”